Related Experiment Video
Updated: Jun 9, 2026

In Vivo Imaging Systems (IVIS) Detection of a Neuro-Invasive Encephalitic Virus
Published on: December 2, 2012
JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with
Caroline F Ryschkewitsch1, Peter N Jensen, Maria Chiara Monaco
1Laboratory of Molecular Medicine and Neuroscience, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
JC virus (JCV) DNA in the cerebrospinal fluid (CSF) provides the laboratory confirmatory diagnosis of progressive multifocal leukoencephalopathy (PML) in patients whose clinical symptoms and magnetic resonance imaging findings are consistent with PML.The Laboratory of Molecular Medicine and Neuroscience (LMMN), National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), made the confirmatory laboratory diagnosis in 35 multiple sclerosis (MS) patients treated with natalizumab. Thirteen patients had 3 or more CSF samples taken from weeks to months following PML diagnosis. Seven of the 13 patients demonstrated persistence of JCV DNA in the CSF even though all patients experienced immune reconstitution inflammatory syndrome (IRIS), 11 patients had plasma exchange, and 2 had immunoabsorption. Specific anti-JCV antibody was measured in plasma/sera samples from 25 of the 35 patients. Most of the samples showed moderate to high or rising antibody levels from the time of PML diagnosis. However, plasma from 1 patient at or near the time of PML diagnosis had a titer considered seronegative and 2 other plasma samples from patients had titers considered at baseline for seropositivity. In several PML cases, viral persistence and neurological deficits have continued for several years, indicating that once initiated, JCV infection may not entirely clear, even with IRIS.
Insights
JC virus (JCV) DNA detection in cerebrospinal fluid (CSF) confirms progressive multifocal leukoencephalopathy (PML). JCV DNA can persist in CSF even after treatment, indicating the virus may not be fully cleared.
Area of Science:
- Neurovirology
- Immunology
- Clinical Neurology
Background:
- JC virus (JCV) DNA in CSF is crucial for diagnosing progressive multifocal leukoencephalopathy (PML).
- Natalizumab treatment for multiple sclerosis (MS) is associated with an increased risk of PML.
- Understanding JCV persistence is vital for managing PML, especially in immunocompromised patients.
Purpose of the Study:
- To investigate the persistence of JCV DNA in CSF of natalizumab-treated MS patients diagnosed with PML.
- To analyze anti-JCV antibody levels in relation to JCV DNA persistence and disease course.
- To evaluate the long-term viral shedding and neurological outcomes in PML patients.
Main Methods:
- Confirmatory laboratory diagnosis of PML using JCV DNA detection in CSF samples.
- Longitudinal analysis of multiple CSF samples from PML patients.
- Measurement of specific anti-JCV antibodies in plasma/sera.
- Monitoring of clinical status, including immune reconstitution inflammatory syndrome (IRIS) and neurological deficits.
Main Results:
- JCV DNA was detected in the CSF of 35 natalizumab-treated MS patients diagnosed with PML.
- Seven of 13 patients showed persistent JCV DNA in CSF despite treatments like IRIS, plasma exchange, and immunoabsorption.
- Most patients exhibited moderate to high or rising anti-JCV antibody levels, though some had atypical serological profiles at diagnosis.
- Viral persistence and neurological deficits continued for several years in some cases.
Conclusions:
- JCV DNA can persist in the CSF of PML patients even after therapeutic interventions.
- The findings suggest that JCV infection may not be completely cleared, even with immune reconstitution.
- Long-term viral persistence highlights the challenges in managing PML and its associated neurological sequelae.
More Related Videos
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
10:15Intracerebroventricular Viral Injection of the Neonatal Mouse Brain for Persistent and Widespread Neuronal Transduction
Published on: September 15, 2014
Related Concept Videos
Cytomegalovirus Disease
Encephalitis ll: Pathophysiology
Multiple Sclerosis l: Introduction
Cryptococcal Meningitis
Arboviral Encephalitis
Encephalitis l: Introduction